GC Biopharma (006280.KS) Stock Price
GC Biopharma Price
Revenue has compounded at 8.7% per year over the past 19 years to 1.99 T KRW. Earnings per share have grown at 4.0% per year over the last 16 years. GC Biopharma's net margin stands at -0.2%, down from 8.0% several years earlier. GC Biopharma currently offers a dividend yield of about 1.17%. The dividend has grown at 4.2% per year over the past 18 years. Analysts set a median price target of 209,100.00 KRW, implying 63.2% above the current price. Of 16 analysts, 15 rate the stock a buy — an overall Buy consensus.
GC Biopharma stock price
GC Biopharma business model & stock analysis
Frequently asked questions about GC Biopharma
Analysts currently set an average price target of 208,386.00 KRW for the GC Biopharma stock (median: 209,100.00 KRW), implying +62.7 % versus the latest price. The consensus is based on 16 analyst ratings.
16 analysts currently rate the GC Biopharma stock: 15 recommend buying, 1 holding and 0 selling. For 2026, analysts expect GC Biopharma to generate revenue of 1.97 T KRW and earnings per share of 15,736.91 KRW.
Converted at the current exchange rate, the GC Biopharma share trades at 85.18 EUR (128,100.00 KRW).
The GC Biopharma share (006280.KS) is listed on 1 stock exchanges, including: KOSPI (Seoul) (006280.KS).
The expected revenue of GC Biopharma is 1.97 T KRW. This figure is based on current financial data and reflects the company's business performance.
The expected profit of GC Biopharma is 179.61 B KRW. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of GC Biopharma is currently 8.14. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the GC Biopharma stock.
The price-to-sales ratio (P/S) of GC Biopharma is currently 0.74. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the GC Biopharma stock.
The Eulerpool Quality Score for GC Biopharma is 3/10.
The ISIN of GC Biopharma is KR7006280002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of GC Biopharma is 006280.KS. The ticker symbol is used to trade GC Biopharma shares on the stock exchange.
GC Biopharma stock
GC Biopharma Peer Group
GC Biopharma Ticker
GC Biopharma FIGI
All fundamentals and in-depth analysis of GC Biopharma
Our stock analysis for GC Biopharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of GC Biopharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.